Literature DB >> 24899460

Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.

Atsushi Kawase1, Ayami Ito, Ayano Yamada, Masahiro Iwaki.   

Abstract

Hepatic transporters and metabolic enzymes affect drug pharmacokinetics. Limited information exists on the alteration in mRNA levels of hepatic transporters and metabolic enzymes with aging. We examined the effects of aging on the mRNA levels of representative hepatic drug transporters and metabolic enzymes by analyzing their levels in 10-, 30- and 50-week-old male and female rats. Levels of mRNA of drug transporters including multidrug resistance protein (Mdr)1a, multidrug resistance-associated protein (Mrp)2, breast cancer resistance protein (Bcrp) and organic anion-transporting polypeptide (Oatp)1a1, and the metabolic enzymes cytochrome P450 (CYP)3A1, CYP3A2 and UDP-glucuronosyltransferase (UGT)1A1 were analyzed using real-time reverse transcriptase polymerase chain reaction. The mRNA levels of transporters in male rats did not decrease with age, while the mRNA levels of Bcrp and Oatp1a1 in female rats decreased with age. The mRNA levels of CYP3A1 and CYP3A2 in male rats were higher than those in female rats. The mRNA levels of metabolic enzymes decreased with age in female but not male rats. In particular, the mRNA levels of UGT1A1 in 10-week-old female rats were higher than those in male rats. mRNA expression of hepatic transporters and metabolic enzymes are more susceptible to aging in female than male rats. The age-related decreases in the mRNA levels of Bcrp, Oatp1a1, CYP3A1 and CYP3A2 in female rats may affect the metabolism and transport of substrates. This study showed that aging affected the mRNA expression of hepatic transporters and metabolic enzymes in rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899460     DOI: 10.1007/s13318-014-0208-7

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  46 in total

1.  Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: the female DA rat is not always an animal model for poor metabolizers of CYP2D6.

Authors:  Hiroshi Komura; Masahiro Iwaki
Journal:  J Pharm Sci       Date:  2005-02       Impact factor: 3.534

Review 2.  Developmental aspects of drug conjugation, with special reference to glucuronidation.

Authors:  G J Dutton
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

3.  Gender-specific expression of liver organic anion transporters in rat.

Authors:  D Rost; K Kopplow; S Gehrke; S Mueller; H Friess; C Ittrich; D Mayer; A Stiehl
Journal:  Eur J Clin Invest       Date:  2005-10       Impact factor: 4.686

4.  Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.

Authors:  Oliver Burk; Katja A Arnold; Andreas K Nussler; Elke Schaeffeler; Ekaterina Efimova; Bonnie A Avery; Mitchell A Avery; Martin F Fromm; Michel Eichelbaum
Journal:  Mol Pharmacol       Date:  2005-03-10       Impact factor: 4.436

Review 5.  Effect of maturation on drug disposition in pediatric patients.

Authors:  C F Stewart; E M Hampton
Journal:  Clin Pharm       Date:  1987-07

6.  Hormonal regulation of microsomal cytochrome P450 2C11 in rat liver and kidney.

Authors:  G F Chen; M J Ronis; P E Thomas; D J Flint; T M Badger
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

7.  Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk.

Authors:  Loïc Le Marchand; Timothy Donlon; Ann Seifried; Lynne R Wilkens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

8.  Interference with growth hormone stimulation of hepatic cytochrome P4502C11 expression in hypophysectomized male rats by 3-methylcholanthrene.

Authors:  Y E Timsit; D S Riddick
Journal:  Toxicol Appl Pharmacol       Date:  2000-03-01       Impact factor: 4.219

9.  Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways.

Authors:  Xingguo Cheng; Jonathan Maher; Matthew Z Dieter; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-05-26       Impact factor: 3.922

10.  Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.

Authors:  Tatsuya Suzuki; Ying Lan Zhao; Masayuki Nadai; Kazumasa Naruhashi; Akemi Shimizu; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Life Sci       Date:  2006-02-17       Impact factor: 5.037

View more
  5 in total

Review 1.  The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids.

Authors:  Aedín Cassidy; Anne-Marie Minihane
Journal:  Am J Clin Nutr       Date:  2016-11-23       Impact factor: 7.045

2.  Age-associated changes of cytochrome P450 and related phase-2 gene/proteins in livers of rats.

Authors:  Shang-Fu Xu; An-Ling Hu; Lu Xie; Jia-Jia Liu; Qin Wu; Jie Liu
Journal:  PeerJ       Date:  2019-08-02       Impact factor: 2.984

3.  Metabolic protection by the dietary flavonoid 7,8-dihydroxyflavone requires an intact gut microbiome.

Authors:  Priyanka Sharma; Camila Silva; Sarah Pfreundschuh; Hong Ye; Harini Sampath
Journal:  Front Nutr       Date:  2022-08-17

4.  ABCG2 in peptic ulcer: gene expression and mutation analysis.

Authors:  Aleksandra Salagacka-Kubiak; Marta Żebrowska; Agnieszka Wosiak; Mariusz Balcerczak; Marek Mirowski; Ewa Balcerczak
Journal:  J Appl Genet       Date:  2015-11-17       Impact factor: 3.240

5.  Extracellular serine and glycine are required for mouse and human skeletal muscle stem and progenitor cell function.

Authors:  Brandon J Gheller; Jamie E Blum; Esther W Lim; Michal K Handzlik; Ern Hwei Hannah Fong; Anthony C Ko; Shray Khanna; Molly E Gheller; Erica L Bender; Matthew S Alexander; Patrick J Stover; Martha S Field; Benjamin D Cosgrove; Christian M Metallo; Anna E Thalacker-Mercer
Journal:  Mol Metab       Date:  2020-10-23       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.